NMT Medical Inc. plans to begin analyzing the data from a clinical trial of its StarFlex cardiac implant ahead of schedule.
The Boston-based device maker said it will begin analyzing data from the CLOSURE I clinical trial of its StarFlex implant in April of next year, ahead of its fall 2010 target date.